Sebana Medical ^{For Profit}

Sebana Medical is a biopharmaceutical company developing a new type of dermal filler. The goal of the product is to prevent fat cell reabsorption following soft tissue augmentation. It designs the technology to incorporate its formulation with the autologous fat during the fat-grafting procedure. This formulation has the ability to release its active drug ingredient locally and gradually in the injected fat to prevent fat cell reabsorption during the critical period after fat transplantation. Its drug has the potential to address and treat a variety of common medical conditions that include soft tissue reconstructions due to congenital malformation and mastectomy, and cosmetic procedures such as wrinkle removal and breast augmentation.